Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...

Small blue round cells of Ewing Sarcoma. Nat Pernick, CC BY 3.0, via Wikimedia Commons Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. A ...

Recent advances in the biological and molecular understanding of rare uterine tumors have expanded therapeutic options for patients. Uterine cancers are a highly heterogeneous group of cancers that ...

Fragmented care - receiving medical treatment at more than one facility - has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...

Fragmented care — receiving medical treatment at more than one facility — has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...

Ziftomenib plus Gleevec is being tested in a phase 1 trial for advanced GIST after Gleevec progression, showing promise in preclinical models. The combination targets GIST tumor weaknesses via a ...

Gastrointestinal bleeding in GIST patients significantly impacts recurrence-free and overall survival, with gastric bleeding linked to worse prognosis. Bleeding is less common in the small intestine, ...

The ORR was 70% in patients treated with remestemcel-L, with 30% having a complete response and 41% having a partial response. The Food and Drug Administration (FDA) has approved Ryoncil ® ...

In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...